📝 $32M Seed's are back

Hey #

Yup, if you're an LOI reader, then you know what that number over there ↖ means.

For those that don't, well that's your subscriber # which means you were one of the first folks to find and join VCinsights.co 👊

As a favor... if you're enjoying the weekly summaries, we'd love a like on our LinkedIn post from today

Enjoy!

--

p.s. if you loved this newsletter, forward it to a friend. And if you hated it... well... maybe send it to an enemy?

And Now, The Memos...

🎮 PLAI Labs (gaming)

PLAI Labs is building the next generation of social platforms.

Raise: Seed | US$32M

Investor Memo: a16z by Arianna Simpson, Andrew Chen, and Robin Guo

"We believe that the future of social networks begins with games, and the best games have strong communities, enticing core gameplay, and robust meta-progression systems that together define how players interact and socialize with each other. Web3 games in particular have the opportunity to create the decentralized metaverse of the future with their distributed infrastructure and focus on empowering players through asset ownership."

 

đź§‘ Goldenset Collective (creator economy)

Goldenset is a platform to invest in and support the next generation of digital creators.

Raise: Seed | US$10M

Investor Memo: Lerer Hippeau

"Goldenset has already inked partnerships with seven leading digital creators, and is well-positioned to own this space going forward. With favorable talent terms that allow creators to stay creative while maintaining personal financial stability, Goldenset aligns with long-term success rather than short-term profits, and because we’re still early in sculpting a digital future, this sort of model makes sense."

đź’‰ Setpoint Medical (biotech)

SetPoint Medical is developing novel bioelectronic medicine therapies to treat those who suffer from autoimmune diseases such as rheumatoid arthritis, Crohn's Disease and multiple sclerosis.

Raise: Growth Equity | US$80M

Investor Memo: Norwest Venture Partners

“SetPoint’s therapy has the potential to meaningfully reduce the cost of care for autoimmune diseases.”

The company is currently enrolling the second stage of its pivotal trial which began last fall, after the FDA completed an interim review of the results from the first 60 patients that were enrolled in the study and gave the company permission to proceed with the trial."

đź’Ł Vannevar Labs (defense tech)

Vannevar Labs is a defense technology company bringing together government expertise with Silicon Valley engineering to solve some of the most important national security problems.

Raise: Series B | US$75M

Investor Memo: Felicis Ventures

"Government groups like the DoD know that in order to deal with the shifting geopolitical landscape — from instability in Europe to threats in Asia — they need the most advanced technological tools and resources to effectively defend and safeguard the nation. Enter Vannevar Labs, whose first product, Decrypt, enables military and foreign policy decision-makers to comprehend, target, and respond to foreign entities through the use of powerful AI."

đź’» Amberflo (CFO tech)

Amberflo allows you to rapidly deploy and scale metering infrastructure, as well as build and operate modern usage-based pricing plans.

Raise: Series A | US$15M

Investor Memo: Norwest Venture Partners by Rama Sekhar & Sanchana Vasikaran

"The usage-based pricing trend is already underway. Snowflake, Confluent, and MongoDB are all examples of successful companies that—out of necessity—built their own UBP infrastructure. Now, Amberflo offers an out-of-the-box solution so companies can avoid building this in-house. After speaking with many product leaders over the past year, Amberflo’s manageability, flexibility, and reliability made it an easy decision to buy versus build."

--

p.p.s. to search, filter and read the full database 1,500+ memos head to VCinsights.co